Theophylline Treatment for Pseudohypoparathyroidism - Children 2-12 Years Old

Clinical trial NCT04551170 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT04551170
Sponsor: Vanderbilt University Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Pseudohypoparathyroidism Albright Hereditary Osteodystrophy Pseudohypoparathyroidism Type 1a

Start date: 2020-07-13
Primary completion: 2026-12-31
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.